Pfizer (PFE) Receivables - Net (2009 - 2026)
Pfizer's Receivables - Net came in at $12.49 billion for Q2 2026, up 3.4% from $12.08 billion a year earlier but down 0.8% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Receivables - Net (2009 - 2026) Analysis & Trends
At the end of FY2025, Pfizer's Receivables - Net was $11.87 billion, up 3.6% from FY2024.
- Receivables - Net carries a five-year compound annual growth rate of 8.5% (FY2020 to FY2025).
- Going back by year, Receivables - Net was $11.46 billion in FY2024 (-0.9%), $11.57 billion in FY2023 (+5.6%), $10.95 billion in FY2022 (-4.6%) and $11.48 billion in FY2021 (+45.1%).
- The five-year range for quarterly Receivables - Net is $10.23 billion (Q2 2023) to $15.16 billion (Q2 2022).
- Year-over-year, Receivables - Net has increased for three consecutive quarters, with growth averaging 3.5% over the last seven quarters.
- The fastest year-over-year change in Receivables - Net over five years came in Q4 2021 (growth of 45.1%), and the weakest in Q2 2023 (a decline of 32.5%).
- Business Quant data shows PFE's Receivables - Net at $12.59 billion (Q1 2026), $11.87 billion (Q4 2025) and $14.26 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 12.49 Bn |
| Mar 29, 2026 | 12.59 Bn |
| Dec 31, 2025 | 11.87 Bn |
| Sep 28, 2025 | 14.26 Bn |
| Jun 29, 2025 | 12.08 Bn |
| Mar 30, 2025 | 11.85 Bn |
| Dec 31, 2024 | 11.46 Bn |
| Sep 29, 2024 | 14.45 Bn |
| Jun 30, 2024 | 11.39 Bn |
| Mar 31, 2024 | 10.99 Bn |
| Dec 31, 2023 | 11.57 Bn |
| Jul 2, 2023 | 10.23 Bn |
| Apr 2, 2023 | 12.31 Bn |
| Dec 31, 2022 | 10.95 Bn |
| Jul 3, 2022 | 15.16 Bn |
| Apr 3, 2022 | 13.23 Bn |
| Dec 31, 2021 | 11.48 Bn |
| Oct 3, 2021 | 11.90 Bn |
| Jul 4, 2021 | 10.59 Bn |
| Apr 4, 2021 | 9.86 Bn |
API Access
Pfizer Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();